Healthcare provider profile · identity verified

Mary L Olson, MD

Family Practice · WINDOM, MN · NPI 1598738387

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	427	76
Lisinopril	Lisinopril	312	58
Simvastatin	Simvastatin	312	58
Metoprolol Succinate	Metoprolol Succinate	275	45
Omeprazole	Omeprazole	201	41
Furosemide	Furosemide	198	30
Metoprolol Tartrate	Metoprolol Tartrate	175	32
Losartan Potassium	Losartan Potassium	172	34
Hydrochlorothiazide	Hydrochlorothiazide	151	33
Metformin Hcl	Metformin Hcl	148	32
Amlodipine Besylate	Amlodipine Besylate	146	29
Atorvastatin Calcium	Atorvastatin Calcium	137	27
Famotidine	Famotidine	135	27
Trulicity	Dulaglutide	105	15
Eliquis	Apixaban	102	13
Pantoprazole Sodium	Pantoprazole Sodium	96	19
Duloxetine Hcl	Duloxetine Hcl	89	16
Citalopram Hbr	Citalopram Hydrobromide	88	19
Rosuvastatin Calcium	Rosuvastatin Calcium	85	23
Venlafaxine Hcl Er	Venlafaxine Hcl	83	suppressed
Gabapentin	Gabapentin	80	20
Lorazepam	Lorazepam	80	17
Potassium Chloride	Potassium Chloride	74	15
Metformin Hcl Er	Metformin Hcl	70	13
Allopurinol	Allopurinol	67	14
Tramadol Hcl	Tramadol Hcl	66	16
Jantoven	Warfarin Sodium	58	suppressed
Bupropion Xl	Bupropion Hcl	49	suppressed
Buspirone Hcl	Buspirone Hcl	47	suppressed
Trazodone Hcl	Trazodone Hcl	46	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Alendronate Sodium	Alendronate Sodium	40	12
Tamsulosin Hcl	Tamsulosin Hcl	39	suppressed
Warfarin Sodium	Warfarin Sodium	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Sertraline Hcl	Sertraline Hcl	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Montelukast Sodium	Montelukast Sodium	31	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	28	suppressed
Cartia Xt	Diltiazem Hcl	28	suppressed
Ibuprofen	Ibuprofen	28	12
Carvedilol	Carvedilol	27	suppressed
Digoxin	Digoxin	27	suppressed
Amoxicillin	Amoxicillin	26	11
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Metolazone	Metolazone	24	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	12
Mupirocin	Mupirocin	19	12
Nystatin	Nystatin	19	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	18	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Estradiol	Estradiol	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Azithromycin	Azithromycin	16	14
Donepezil Hcl	Donepezil Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Baclofen	Baclofen	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	11
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Pravastatin Sodium	Pravastatin Sodium	14	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Cefdinir	Cefdinir	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Fluconazole	Fluconazole	12	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ozempic	Semaglutide	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ramipril	Ramipril	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error